The role of radiotherapy in the treatment of oligometastatic non-small cell lung cancer
In the recent years, the clinical stage where the cancer has spread beyond the primary site, but has not yet metastasised extensively, and which is known as oligometastatic disease (OMD), has become an object of interest to radiation oncologists. OMD is a kind of an “umbrella term” for a variety of...
Saved in:
| Main Author: | Radovan Vojtišek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Via Medica
2025-01-01
|
| Series: | Reports of Practical Oncology and Radiotherapy |
| Subjects: | |
| Online Access: | https://journals.viamedica.pl/rpor/article/view/107745 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metastasis directed radiotherapy versus standard of care for PSMA-PET diagnosed oligometastatic/oligoprogressive castration resistant prostate cancer
by: Laura Bauersachs, et al.
Published: (2025-07-01) -
Evaluation of the optimal timing of radiotherapy in EGFR-Mutant oligometastatic NSCLC through a retrospective analysis of treatment sequences and survival outcomes
by: Meng Zhang, et al.
Published: (2025-08-01) -
Silencing PinX1 enhances radiosensitivity and antitumor-immunity of radiotherapy in non-small cell lung cancer
by: Jieping Qiu, et al.
Published: (2024-03-01) -
Efficacy and safety of upfront radiotherapy with immune checkpoint inhibitors for brain metastasis in non-small cell lung cancer
by: Yu Tanaka, et al.
Published: (2025-01-01) -
Advances in Radiotherapy for Extensive-stage Small Cell Lung Cancer
in the Era of Immunotherapy
by: Tingting CHEN, et al.
Published: (2025-05-01)